TYRA
Tyra Biosciences Inc
22.40$
-3.5%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | |
| – | +487.5% | +197.9% | +111.4% | +19.3% | +47.0% | +5.2% | |
| – | – | – | – | – | – | – | |
| – | +302.4% | +186.5% | +108.4% | +45.4% | +28.1% | +28.5% | |
| – | +57.2% | +169.9% | +181.7% | +9.5% | +38.3% | +23.8% | |
| – | +196.3% | +184.2% | +124.2% | +35.7% | +30.3% | +27.4% | |
| – | – | – | – | – | – | – | |
| – | +0.0% | +13,900.0% | +111.4% | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.